Ginkgo bioworks announces pathogen monitoring program at kigali international airport

The program establishes a new node in a global early warning network for emerging variants to support timely and targeted public health response boston and kigali, rwanda , feb. 15, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, and the rwanda biomedical centre (rbc) today announced a one-year pathogen monitoring program at rwanda's kigali international airport (kgl) to identify new and emerging variants of sars-cov-2. through this program, ginkgo's biosecurity and public health unit, concentric by ginkgo , will collaborate with rbc to monitor wastewater samples from arriving aircraft and nasal swab samples, collected on a voluntary, anonymous basis from arriving international travelers, for sars-cov-2.
DNA Ratings Summary
DNA Quant Ranking